TNF and prostate cancer: More recently, Kim et al. demonstrated that 20(S)-Rg3 sensitized prostate cancer cells to docetaxel and other chemotherapeutics by inhibiting cell growth and augmenting apoptosis via suppression of constitutively activated and TNFα-induced NF-κB [42].